24 employees
Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.
2021
$30M
from 8 investors over 8 rounds
Sensorium Therapeutics raised $30M on October 4, 2022
Investors: Ocama Partners, CU Healthcare Innovation Fund, re.Mind Capital, -, Route 66 Ventures, LLC, -, Palo Santo and Iter Investments